Page last updated: 2024-08-21

dihydroergotamine and flunarizine

dihydroergotamine has been researched along with flunarizine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arteaga Manjón-Cabez, R; Herranz Fernández, J; Lastra Martínez, L1
Soyka, D1
Bousser, MG; Massiou, H1
Gerber, WD; Langohr, HD; Mangold, R; Reinecke, M1
Heidrich, H1
Cano, A; Roquer, J1
Titus, F1
Henry, P1

Reviews

1 review(s) available for dihydroergotamine and flunarizine

ArticleYear
[Flunarizine and dihydroergotamine in the treatment of migraine in children].
    Anales espanoles de pediatria, 1990, Volume: 32, Issue:3

    Topics: Age Factors; Child; Child, Preschool; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Migraine Disorders; Parents

1990

Trials

3 trial(s) available for dihydroergotamine and flunarizine

ArticleYear
[Flunarizine and dihydroergotamine in the treatment of migraine in children].
    Anales espanoles de pediatria, 1990, Volume: 32, Issue:3

    Topics: Age Factors; Child; Child, Preschool; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Migraine Disorders; Parents

1990
[Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study].
    Fortschritte der Medizin, 1988, Jan-20, Volume: 106, Issue:2

    Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders

1988
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Deutsche medizinische Wochenschrift (1946), 1985, Aug-02, Volume: 110, Issue:31-32

    Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine

1985

Other Studies

5 other study(ies) available for dihydroergotamine and flunarizine

ArticleYear
[Beta receptor blockers in migraine].
    Deutsche medizinische Wochenschrift (1946), 1985, Feb-01, Volume: 110, Issue:5

    Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Cinnarizine; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Hypotension; Migraine Disorders; Time Factors

1985
[Antimigrainous agents used in maintenance treatment].
    La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnarizine; Clonidine; Dihydroergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol

1986
[Ambulatory care of chronic headache secondary to abuse of ergot preparations].
    Atencion primaria, 1996, Feb-29, Volume: 17, Issue:3

    Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dihydroergotamine; Ergot Alkaloids; Female; Flunarizine; Headache; Humans; Male; Middle Aged; Naproxen; Prospective Studies; Substance-Related Disorders; Time Factors; Vasodilator Agents

1996
[The treatment of migraine].
    Revista de neurologia, 1997, Volume: 25, Issue:138

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

1997
[Migraine: a disease, not a symptom].
    La Revue du praticien, 2002, Jan-01, Volume: 52, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Diagnosis, Differential; Dihydroergotamine; Flunarizine; GABA Agents; Humans; Indoramin; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents

2002